DSM-Firmenich AGDSFIR.AS

Euronext AmsterdamMaterialsSpecialty Chemicals
Price (close)
€97.78
Market cap
€23.9B
P/E
—
Revenue (FY)
€9.0B
Net income
-€1.1B
Dividend yield
2.56%
1-year total return
40.1%
Net margin
-12.3%
Revenue growth
-29.4%
Debt / equity
0.26x

What DSM-Firmenich AG does.

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Revenue€8.4B€10.6B€12.8B€9.0B
Net income€1.7B€2.1B€222.0M-€1.1B
Free cash flow€281.0M€710.0M€1.1B€651.0M

More on DSFIR.AS.

Figures from DSM-Firmenich AG's annual reports (ESEF, via filings.xbrl.org) and Yahoo Finance, standardised automatically; prices are end-of-day closes. Not financial advice.